Figure 3From: Identification of a chromatin regulator signature and potential candidate drugs for bladder cancerConstruction of the prognostic CR-based signature in TCGA set. A. Kaplan-Meier survival analysis of BLCA patients between high-risk groups and low-risk groups in TCGA set; B. Time-independent receiver operating characteristic (ROC) analysis of risk scores predicting the overall survival in TCGA set; C. Distribution of survival status based on the median risk score in TCGA set; D. Heatmap showed the differences of 11 chromatin regulators between high and low-risk patients in TCGA setBack to article page